The U.S. Food and Drug Administration finally approved Wednesday the commercialization of a “female Viagra” after its third attempt and an intense public relations campaign launched by the pharmaceutical company in the name of feminism.

“Addyi,” the name of the future drug invented by Spout Pharmaceutical, had failed to pass the agency's approval in previous attempts since 2010 on the ground that its side effects outweighed its benefits.

However, 18 judges out of 24 ruled Tuesday that fainting or extremely low blood pressure – effects exacerbated when the pill is mixed with alcohol or hormonal contraception – were less important than giving the right to women to enjoy sex as much as men.

In five years, the FDA did not reverse its initial verdict despite new evidence of the drug's benefits. What changed was the pharmaceutical group's promotion strategy, created in 2014 and partly funded in Washington, D.C., by an advocacy group called Even the Score.

The group, reported Buzzfeed, carried out an intense lobbying campaign with women groups and lawmakers, encouraging them to accuse the FDA of being sexist. By shifting the perspective from health to women's rights, the advocacy group seemed to be fighting an easier battle, as indeed only men can access drugs treating sexual health issues.

RELATED: Women Resist

This so-called feminist argument has nevertheless been questioned by other feminist groups.

First, the pink pill (as opposed to the blue pill of male Viagra – let's not push too far progressivism on gender equality and stereotypes) is supposed to cure the much more elusive nervous arousement in women's brains.

Luckily for the company, however, some psychiatrists have even invented a name for “frigid” and frustrated women: hypoactive sexual desire disorder (HSDD), a chronic or ongoing lack of interest in sex that may cause a woman distress, supposedly due to depression, stress, and low self-esteem.

“What this acronym cannot address – because it cannot name it – is boredom, exhaustion, resentment, and dull old relationships: the things that may dampen sexual desire,” claimed columnist Guardian Suzan Moore.

Dr. Petra Boynton, a psychologist quoted in another Guardian report, said losing interest in sex is a real worry for women: “But what are they actually worried about? They think they are not normal because they don’t want sex that much. They wonder, ‘Will my partner leave me?’ and, ‘Am I undesirable or inadequate?’”

Could that possibly mean that the pill ends up serving the male interests in making women more suited to their own desires?

Meanwhile, they surely will not need to worry too much about how to best sexually please their partners.